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INTRODUCTION 
Atherosclerosis contributes to increasing mortality and morbidity.  
A simple and a non invasive and bedside test –The ABI can be used to predict 
the atherosclerotic cardiovascular events even in primary care settings.  
An ABI less than 0.9 is an indicator of atherosclerotic vascular diseases in 
different vascular territories.  
 It is sensitive and specific as angiography. 
 Both symptomatic and asymptomatic patients with atherosclerosis and 
peripheral vascular disease are at increased risk of adverse cardiovascular 
events.  
Data from National health and Nutrition Examination Survey (NHANES) 
shows that the prevalence of Peripheral vascular disease among people aged 
over 70 years of age is three times more when compared to patients between 40 
to 50 years of age. 
70 percent of PAD patients have atherosclerotic sequelae in some other 
vascular bed. 
Well controlled and repeated ABI measurements by practitioners are enough as 
clinical gatekeepers for decision making. 
 Considering all the above factors this study is being undertaken.  
 
  
 
 
AIMS AND OBJECTIVES 
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AIMS AND OBJECTIVES 
1. To determine the relationship between peripheral artery disease and 
coronary artery disease in high risk population using Ankle Brachial 
Index. 
2. To study the relationship between various risk factors like blood 
pressure,diabetes and dyslipidemia and Ankle Brachial Index values 
3. To study the influence of aging process and the relation to ABI 
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REVIEW OF LITERATURE 
1. The correlation between peripheral arterial disease and coronary artery 
disease using ankle brachial index was done by Sarangi et al 
    The study was conducted in inpatients older than 45 years who were 
randomly selected and had one or more risk factors for peripheral vascular 
disease. 
    Based on ABI value of <0.9, PAD was diagnosed in 32 out of the 182 
patients studied that is , 18  percent of the study population. Coronary artery 
disease was present in 15 cases of peripheral arterial disease patients which is 
statistically significant number of patients. 
2. The relation between ankle brachial index and coronary artery disease 
severity and risk factors-an angiographic study was conducted by 
Sadeghi et al 
     This study is a cross sectional descriptive analytic research study on patients 
with suspected CAD. Characteristics of the study population were obtained 
using a standard questionnaire that included family history, past history, and 
the conventional atherosclerotic risk factors including diabetes, hypertension, 
hyperlipidemia and smoking. An ABI value of <0.9 was considered positive 
that is patient was diagnosed a s peripheral arterial disease and an ABI value of 
>0.9 was considered a s ABI negative that is normal. The study subjects were 
subjected to coronary angiography and the results of the questionnaire and the 
angiographic findings were compared between the two study groups. Out of the 
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125 patients studied low ABI was seen in 25 patients (20 percent).The 
prevalence of ABI positive among men were 25.9 percent and 7.5 percent 
respectively. The prevalence of risk factors for atherosclerosis were 
significantly higher among the ABI positive group and the ABI positive 
patients had a more severe stenosis. The mean value of occlusion of different 
coronary vessels was also significantly higher in the ABI positive group with 
the left main coronary, right coronary artery, left anterior descending artery, 
diagonal artery 1 and left circumflex artery involvements(p value<0.05) 
3. IMPACT ABI trial(Impressive predictive value of ankle brachial index 
for long term outcomes in patients with cardiovascular disease 
This study was a retrospective cohort study done in a single center where 3131 
patients were enrolled, who were hospitalized for cardiovascular disease. The 
age of the population studies 54 to 80 years. Patients were categorized into low 
(≤ 0.9), borderline(0.9-0.99) and normal ABI(>1).The primary endpoint was 
MACE(major acute cardiovascular event). 
    The study concluded that during a follow up period of 4.8 years incidence of 
MACE(low vs borderline vs normal):32.9% vs 25% vs 14.6 % with a p value 
of <0.0001 the cardiovascular deaths also differed significantly across ABI 
(26.2% vs 18.7% vs 8.9 percent ) with a p value of <0.0001 %. 
4. Sukhija R et al studied the correlation of ankle brachial index with the 
severity of coronary artery disease in 273 patients whose mean age was 17 
years with peripheral arterial disease. These patients had obstructive coronary 
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artery lesions(>50% occlusion).Out of the 155 patients with an ABI of 
<0.40,130 patients had 3 to 4 vessel disease which accounted for 84 
percentage.11 % of them had double vessel disease and 5 percent had single 
vessel Coronary artery disease from which they concluded that as the ABI 
values are lower there occurred more prevalence of 3 or 4 vessel coronary 
artery disease than single vessel disease 
5. In the study done by Eduardo d et al prospective analysis of the data from 
100 patients with coronary artery disease as confirmed using coronary 
angiogram and with more than 70 percent stenosis of at least one sub epicardial 
coronary artery with  a cutoff value of less than 0.9 as abnormal. 
    The average age of the study population was 77.4 years and the most 
prevalent risk factor was hypertension. The median later follow up appointment 
was at 28.9 months. A low ABI was seen in multiarterial CAD than in 
uniarterial CAD. 
5. Dinaldo et al did a prospective analytical cross sectional study over a period 
of one year that included 163 patients according to the inclusion and exclusion 
criteria. The Poisson regression method was used to assess whether ABI was an 
independent predictor of coronary stenosis more than 50 percent  
They concluded that the patient group with low ABI had higher prevalence of 
stenosis more than 50 percent in the left anterior descending artery and the left 
main coronary artery than those with normal ABI value. 
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6. Felipe and colleagues conducted a study on the relation of ABI and the 
complexity of coronary artery disease which analysed patients more than 65 
years undergoing coronary angiogram for ischaemic heart disease and analysed 
the coronary artery anatomy using the SYNTAX score and the American Heart 
Asssociation Criteria 
In this study that recruited 204 patients with a median age of 72.5 years, stable 
angina was present in 51 percent of the study population. Although peripheral 
vascular disease was clinically present in only 1 percent of the study population 
it was found in 45 percent using ABI measurement. The number of lesions 
present per patient, the number of patients with complex coronary lesions and 
the SYNTAX scores were significantly higher in the abnormal ABI group. This 
study thus concluded that low ABI could discriminate a group of patients with 
greater occurrence of Type B 2 or type C lesions but with similar median 
SYNTAX score in patients more than 65 years.  
7. Moatasem S Amer and colleagues conducted a case control study on the 
association between ABI and coronary artery disease severity among elderly 
Egyptians which included 200 patients aged more than 60 years who were 
divided into 100 cases and 100 controls according to ABI and then evaluated 
the severity of CAD using SYNTAX and Jeopardy scores and number of 
diseased vessels which were significantly high in patients with peripheral 
vascular disease. All of the 3 measures had negative correlation with ABI (p 
value ≤0.001 for Jeopardy,<0.001 for SYNTAX and 0.004 for number of 
diseased vessels). 
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8.The study done by Marlene Grenon which was a prospective cohort study in 
CAD patients symptomatic PAD patients had a higher risk of CV events of 70 
percent(p value 0.04 )and 80% higher risk of death.(p value of 0.006). 
9.in the study conducted by Rosamond, ABI was measured in 12186 patients in 
the atherosclerosis Risk in The community study, and fatal and nonfatal events 
were assessed through phone calls, discharge summaries and death certificates 
and in live patients through ecg taken regularly at 3 year intervals. Participants 
were followed for 13.1 years and Hazard ratios were calculated using the Cox 
regression methods. During the study period almost 964 events(fatal and 
nonfatal) occurred. The hazard ratios were 2.81 for men and for women it was 
2.05. The risk of CHD increased exponentially with decreasing ABI and it 
continued to decrease in patients with ABI of >1 in all age and race and gender 
subgroups. Even lowering of ABI by 0.1 increased the hazard by 25% in white 
women and by 34% in African American men and 32 percent in African 
American females. 
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PERIPHERAL VASCULAR DISEASE 
Peripheral vascular disease is the occlusion of arteries distal to the bifurcation 
of the aorta. It also refers to chronic arterial disease of the legs which is 
atherosclerotic in origin. The WHO defines this pathology as atherosclerosis 
obliterans. Some of the most important studies using ABI like the Framingham 
Heart Study, The San Diego Study, The Rotterdam Study have concluded that 
asymptomatic peripheral arterial disease is much common than the 
symptomatic disease. 
CLASSIFICATION OF LIMB ISCHAEMIA:  
Stage 1-no clinical symptoms 
Stage 2-intermittent claudication 
    2a-well compensated disease where the patient can walk more than 200 
metres 
    2b-poorly compensated- disease where the patient can walk only less than 
200 metres 
Stage 3-rest pain 
Stage 4-gangrene and ischaemic ulcer 
Limb ischaemia is also classified as  
      Functional limb ischaemia 
      Critical limb ischaemia 
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Functional limb ischaemia 
      Here flow of blood to the limbs is normal when limbs are at rest; but will 
not be increased during exercise.  
    It presents clinically as claudication.  
    Claudication is defined as muscle discomfort in the limb reproducibly 
produced by exercise and that will be relieved by rest within 10 minutes. 
Critical limb ischaemia 
      It is persistently recurring ischaemic pain in the limbs for more than two 
weeks which requires regular analgesics for more than 2 weeks or is associated 
with ulceration or gangrene of the foot or toes with an ankle systolic pressure 
<50 mmHg or toe systolic pressure <30mmHg. In these cases the Ankle 
brachial pressure index will be less than 0.3. 
    Claudication is a specific but may not be a sensitive feature of peripheral 
arterial disease. 
    Around 90% patients with an ABI of less than 0.9 may not have 
claudication.(falsely negative) 
    An ABI of 0.9 to 0.99 is considered as borderline ABI value.  
    Such patients may be asymptomatic at rest but experience symptoms due to 
compromised vascular flow while walking or using the limbs 
 
10 
 
INTERPRETATION OF ABI RESULTS: 
    >0.90 is normal ABI 
    0.70-0.89 is mild disease 
    0.50-0.69 is moderate  
    <0.50 is severe 
    >1.3 is due to non compressible severely calcified vessel as is the case in old 
age 
ANKLE BRACHIAL INDEX: 
      It is a very useful tool to indicate the presence of lower extremity peripheral 
arterial disease.  
      It is a very cost effective assessment especially in the primary care setting 
as well as to identify patients at increased risk of lower extremity injury after 
blunt or penetrating trauma to predict the prognosis of limb recovery post 
surgery. 
     An ABI value of less than 0.9 cutoff value has sensitivity of 90% and 
specificity of 98% for detecting a lower extremity stenosis of more than 50%.  
     Previous studies have showed an inverse relation between ABI and 
cardiovascular diseases and atherosclerotic diseases elsewhere. 
     It can detect and predict the existence of CAD in an otherwise 
asymptomatic patient. 
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   The idea of Comparing peripheral versus central pressures was first found by 
Winsor18 using Rubber strain gauge and mercury method. 
ABI can be compared to findings on peripheral angiography and by comparing 
with doppler ultrasound of the lower limb which is the gold standard. 
     SHORTCOMINGS OF ABI: 
    1. An incorrectly done test, probably due to wrong technique may yield false 
positive or false negative results that may lead to either delayed diagnosis of an 
existing disease or to unnecessary treatment for a non existing  disease. 
    2. In patients with heavily calcified blood vessels which are non 
compressible as in the elderly patients and diabetic patients, as a result of 
arterial medial wall calcification the ABI measurements may not be precise and 
there may be false negative ABI.  
    3. About 10 percent of the population may lack the dorsalis pedis or the 
posterior tibial artery thus  make it impossible to measure this non invasive test. 
    4. Certain medications like antihypertensives and antiplatelet drug treatments 
and statin therapy may influence the values of ankle brachial index.    ABI is 
age and blood pressure dependent and these two factors themselves are linked 
to each other. 
   5.  The accepted methodology of current techniques do not make necessary 
corrections for physiological variations over time in baseline blood pressure 
and for other confounding factors like respiratory variations of blood pressure, 
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thus requiring the need to use reference values as a range rather than point 
values 
  6.  As ABI values are mostly from observational studies only, the value of 0.9 
is possibly due to inherent limitation of the methods (noninvasive) used for BP 
measurement using an occlusive cuff without considering control for 
physiological beat to beat variation for example during breathing. Still beat to 
beat variations can be measured only if both upper and lower limb pressures 
are recorded synchronously which is technically cumbersome and hence  not 
recommended by any studies. 
  7.  Technical factors such as over and rapid deflation of the ankle cuff can 
yield falsely low systolic pressures at the ankle. 
Contraindications for ABI measurement 
      ABI measurement is contraindicated in persons in whom the use of an 
occlusive sphygmomanometer cuff during measurement of blood pressure may 
worsen the lower extremity injury  
PREPARATION: 
  Necessary equipments for measuring ABI include 
    Appropriate size cuff for upper and lower extremities with a properly 
working sphygmomanometer 
    Doppler device (Hand held 5 to 10 m Hz ) 
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    Ultrasound gel 
    Examination table 
PREPARATION OF THE PATIENT FOR THE PROCEDURE 
    Patient must lie on the examination table in the supine position 
    No other specific preparation needed 
Technique 
    The patient is made to lie supine with the arms and legs at the heart level for 
atleast 10 minutes prior to blood pressure measurement. 
    Select an appropriate sized BP cuff (whose width would be atleast 20% more 
than the diameter of the limb).  
    The cuff must completely encircle the lower/upper extremity. 
    The ankle cuff should be tied somewhere between the malleolus and the calf 
muscle. 
    Adequate room should be left below the cuffs to permit the placement of the 
ultrasound gel so that the Doppler device would adequately measure the 
brachial ,dorsalis pedis and the posterior tibial pulses. 
    Obtain the systolic pressure of both the arms(brachial artery)  and then select 
the higher value among the two as the brachial systolic pressure.  
    Note that the difference between them should be less than 10 mm Hg only.  
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    The brachial pulse is best felt medial to the biceps tendon at the antecubital 
fossa. 
    Similarly obtain the anterior and posterior tibial systolic pressures of one 
side limb and then select the higher of the two values as the ankle pressure.  
    The posterior tibial arterial pulse is best appreciated just below and dorsal to 
the medial malleolus.  
    The dorsalis pedis pulse is best felt over the dorsum of the foot between the 
proximal part of the first and the second metacarpal boned just above the 
navicular bone and medial to the tendon of the extensor halluces longus.  
    Obtain similar values from the opposite leg and consider the highest value as 
the ankle pressure. 
    Place the Doppler probe over the the arterial landmarks and identify the 
arteries. 
    On application of the arterial probe pulsations should be audible. 
    If the pulsations are not audible then reposition the probe till you can hear 
the pulsations. 
    Doppler probe must be placed at 45 to 60 degrees to the vessel and not at 90 
degrees. 
    Inflate the cuff to around 20 mmHg above the expected systolic pressure.  
    The Doppler sounds now disappear. 
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    Now slowly deflate the cuff at 1 mm/second. 
    Record the pressure point at which the Doppler sounds reappear which gives 
the systolic pressure measurement of that particular limb.  
ANKLE BRACHIAL INDEX CALCULATION: 
           ABI = Ankle systolic pressure/ brachial systolic pressure 
                Calculated by taking the systolic pressure the ankle pressure divided 
by the brachial systolic pressure. Calculated ABI must be recorded to two 
decimal points.  
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MEASUREMENT OF ANKLE BRACHIAL INDEX 
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ATHEROSCLEROSIS 
PATHOGENESIS: 
        It is a chronic complex inflammatory condition of the elastic and muscular 
arteries involving as systemic and segmental disease process. It begins in 
childhood itself as fatty streaks. It is one of the major causes of death and 
disability in the developing countries. Current predictions estimate that by the 
year 2020, Cadiovascular diseases especially atherosclerosis will become the 
leading cause of global total disease burden. Atherosclerosis affects different 
regions of the circulation preferably and has distinct manifestations depending 
on the circulatory bed affected. Atherosclerosis of the coronary arteries cause 
coronary artery disease and angina pectoris. Atherosclerosis affecting the 
central nervous system causes stroke and transient ischaemic attacks. 
Sphlancnic circulation involvement  can cause bowel ischaemia. The kidneys 
can be affected either directly as renal artery stenosis or as a common site for 
atheroembolic disease. Even within a particular arterial bed stenosis due to 
atherosclerosis tends to occur focally especially in certain predisposed regions. 
In the coronary circulation the proximal Left anterior  descending artery is 
more frequently blocked due to atherosclerosis. Similarly atherosclerosis has a 
predilection for the proximal part of the renal arteries and in the extra cranial 
circulation to the brain, the carotid bifurcation. Atherosclerotic lesions form at 
the branching points of the vessels where there would be turbulent flow. 
Ectasia and aneurysmal disease frequently occur in the aorta. In addition to 
focal, flow limiting stenosis, nonocclusive intimal thrombosis also occurs 
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diffusely with high frequency in affected arteries as evidenced by intravascular 
ultrasound and postmortem studies. Atherosclerosis in humans occurs over 
many years usually decades. Growth of atherosclerotic plaques does not occur 
in a smooth linear fashion but rather discontinuously with periods of relative 
quiescence punctuated by periods of rapid evolution.  
        After a generally prolonged silent period, atherosclerosis clinically 
manifests. The clinical expressions may be chronic for example the 
development of stable effort induced angina pectoris or as intermittent 
claudication which is predictable and reproducible. Alternatively in some 
instances, a dramatic acute clinical event like stroke or MI or sudden cardiac 
death may be the first manifestation of the presence of atherosclerosis. Other 
individuals may never experience clinical manifestations of the disease despite 
the presence of extensive atherosclerotic disease in postmortem studies. 
INITIATION OF ATHEROSCLEROSIS 
     Fatty streak represents the initial lesion of atherosclerosis. These very 
early lesions arise from the focal increases in the lipoprotein content within the 
intima. This accumulation of lipoproteins is due to increased permeability or 
leakiness of the vascular endothelium. The lipoproteins also bind to the 
extracellular matrix of the intima thus increasing the residence time of the lipid 
particles, where they bind with the glycosaminoglycans of the arterial 
extracellular matrix which slows the egress of these lipid rich particles from the 
intima. These bound lipoproteins then undergo oxidized modification. Forming 
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hydroperoxides, oxysterols, lysophospholipids and aldehyde breakdown 
products of fatty acids and phospholipids. Modification of the apoprotein 
moieties may occur including the peptide backbone breaks and the 
derivatization of certain amino acid residues.  
          The inflammatory molecules within the plaque contain the enzyme 
myeloperoxidase which cause production of hypochlorous acid HOCL that 
yields chlorinated species like chloro tyrosyl moieties. HDL molecules which 
are thus chlorinated act as poor acceptors of cholesterol a finding that suggests 
impaired reverse cholesterol transport (which is the anti atherogenic 
mechanism of HDL) due to oxidative stress. Lipoprotein associated 
phospholipase A2 which is a member of the phospholipase family can generate 
pro inflammatory lipids including lysophosphatidyl choline bearing oxidized 
lipid moieties from oxidized LDL. 
LEUCOCYTE RECRUITMENT 
     Accumulation of leucocytes characterize the early atherosclerotic 
lesions. The inflammatory cells found in an atheromatous plaque include 
monocyte derived macrophage sand lymphocytes. Various adhesion molecules 
and receptors for leucocytes found on the endothelial surface recruit leucocytes 
on the surface of the atheroma which is augmented by the oxidatively modified 
LDL. Laminar shear forces in normal arteries suppress the expression of 
adhesion molecules. Ordered pulsatile laminar flow causes production of nitric 
oxide which acts a s vasodilator and also acts a local anti-inflammatory 
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autocoid. Also laminar shear stress increases the production of superoxide 
dismutase and inhibits the thioredoxin reducing protein which inhibits the 
activity of the endogenous anti-inflammatory protein thioredoxin. 
Chemoattractant like monocyte chemoattractant proteins direct the migration of 
leucocytes to the vessel wall. 
FOAM CELL FORMATION 
    Once resident within the intima the monocytes transform into macrophages 
and lipid laden foam cells. By receptor mediated endocytosis. Lipid 
accumulation and thus the propensity for atheroma formation ensues if the 
amount of lipid entering the artery wall exceeds that removed by mononuclear 
phagocytes. Lipid overload in the lesion is prevented by export by the 
phagocytes and also by the reverse cholesterol transport by HDL. Thus transfer 
is mediate through specialized cell surface proteins called as ABCA1. 
     Some foam cells may die due to apoptosis which results in the formation of 
lipid rich centre called as the necrotic core. In advanced disease there is build 
up of fibrous tissue by the extracellular matrix. Cytokines present in the plaque 
like TNF and IL1 induce the production of growth factors like PDGF and FGF 
which cause plaque evolution. PDGF causes migration of smooth muscle cells 
from the vascular media to the intima. TGF beta stimulates interstitial collagen 
production by the smooth muscle cells. These mediators not only arise from the 
neighboring cells (paracrine) but also arise from the cell itself (autocrine 
pathway).Products of blood coagulation and thrombosis contribute to atheroma 
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evolution. This justifies the use of the term athero thrombosis. Fatty streak 
forms behind a morphologically normal endothelium. Micro thrombi form at 
the sits of endothelial denudation. Activated platelets release numerous factors 
that can promote the fibrotic response. Thrombin stimulates protease activated 
receptors that can signal smooth muscle proliferation, migration, and 
extracellular matrix production. 
MICROVESSELS 
    Neovascularization occurs in connection with the artery’s vasa vasorum. 
These act as the portal for entry and exit of leucocytes from the atheroma. 
Atherosclerotic plaques often contain fibrin and hemosiderin and later 
accumulate calcium. 
PLAQUE INSTABILITY AND RUPTURE 
    A superficial erosion or a frank plaque rupture causes thrombus that 
precedes the unstable angina or the persistent thrombus causes acute MI. 
Rupture of the fibrous cap  
  causes contact between the coagulation factors and the highly thrombogenic 
tissue factor. The healing process involves the laying down of extracellular 
matrix and fibrosis. Those plaques with thin fibrous cap, large lipid core and 
high content of macrophages are more likely to rupture. In contrast those with 
dense extracellular matrix and a thick fibrous cap without substantial tissue 
factor rich lipid cores are less vulnerable to plaque disruption.   
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          Ulcerated plaque is highly thrombogenic causing thrombosis and further 
critical block of the vessel leading to tissue ischemia and infarction distally. 
Plaques are dynamic in nature with progression and regression phases. Plaque 
progression has a unique property of adaptation so that as the plaque progresses 
lumen caliber is tried to be preserved till critical stenosis occurs. Stenosis 
beyond 40 percent is said to be critical. Beyond this compensatory mechanism 
fails causing rapid progression and further stenosis of lumina. Stenosis more 
than 40 percent causes atrophy of the tunica media and makes the vessel wall 
unstable leading to dilatation and aneurysm. 
    Atherosclerosis is common after 50 years but can occur at an earlier age 
group also. It occurs in males and females as well. Family history is common. 
Veins are not diseased. Arterial wall is thickened on palpation. Features of 
ischemia may be seen in the affected limb. Absent or feeble pulses including 
the main arteries of the limb may occur. Abdomen should be examined for 
aortic aneurysm. 
THE CONCEPT OF ATHEROSCLEROTIC RISK FACTORS: 
      The Framingham Heart Study which was a prospective community based 
study provided immense support to the risk factors contributing to 
atherosclerosis. 
      Risk factors can be classified as those modifiable by lifestyle and 
pharmacotherapy and those that are immutable or are genetically determines 
and thus re non modifiable. 
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      The major risk factors (those that are recognized by the Current National 
Cholesterol Education Project Adult Treatment Panel ATP III) exclusive of 
LDL cholesterol that modify LDL goals 
Smoking 
Hypertension (BP of 140/90 mmHg or on antihypertensive medication) 
Low HDL levels (less than 40 mg/dl) 
Diabetes mellitus 
Family history of coronary artery disease 
    CHD in male first degree relative <55 years or 
    CHD in female first degree relative less than 65 years 
    Age (≥45 years in females and ≥55 years in males) 
Lifestyle risk factors 
    Obesity (BMI >30 kg/ sq.m) 
    Physical inactivity 
    Atherogenic diet 
Emerging risk factors (Non traditional risk factors) 
    Lipoprotein (a) 
    Homocysteine 
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    Prothrombotic factors 
    Impaired fasting glucose 
    Pro inflammatory markers (C reactive protein) 
    Subclinical atherosclerosis 
LIPID DISORDERS: 
    Abnormalities in the lipoproteins and lipid metabolism are among the most 
firmly established factors for atherosclerosis. Lipid profile must be done in all 
adults more than 20 years of age. The screen should include fasting lipid profile 
(Total cholesterol, triglycerides, LDL and HDL) and must be repeated every 5 
years.  
    ATP III guidelines try to match the intensity of treatment to an individual’s 
risk. Patients are divided into three treatment strata. The number of risk factors 
for each person is counted. Individuals with less than 2 risk factors are 
classified a slow treatment intensity arm with an LDL goal of less than 
160mg/dl. Those with more than 2 risk factors are evaluated for 10 year risk of 
ASCVD events. Those with risk score of ≤ 20 % are classified as intermediate 
risk and are treated with a n LDL goal of 130 mg/dl and those with score more 
than 20 percent or any evidence of atherosclerosis or a known diabetic (which 
is now considered as a CHD risk equivalent) fall under the most intensive 
treatment group with an LDL goal of <100 mg/dl. Those with LDL levels 
exceeding their target by at least 30 mg/dl need therapy. Secondary goals 
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include non HDL cholesterol lowering. Cut off points for non HDL cholesterol 
is 30 mg/dl more than that of LDL cholesterol. 
INSULIN RESISTANCE AND THE METABOLIC SYNDROME 
    Aging and obesity underlie the current epidemic of diabetes. The abnormal 
lipid profile seen in diabetics is called as the diabetic dyslipidemia. Although 
the LDL levels are found to be near average in most of the diabetics the LDL 
particles are small and dense and more atherogenic. Other features of diabetic 
dyslipidemia are low HDL and increased triglycerides. Statins should be 
considered for diabetics more than 40 years of age with total cholesterol 
≥135mg/dl. 
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CLINICAL IDENTIFICATION OF THE METABOLIC SYNDROME 
(any three) 
    Abdominal obesity (Waist circumference) 
      Men->102 cm 
      Women->88 cm 
    Triglycerides>150 mg/dl 
    Blood pressure≥135/≥85 mmHg 
    Fasting glucose >110 mg/dl 
    HDL cholesterol 
      Men <40 mg/dl 
      Women <50 mg/dl. 
MALE SEX/POSTMENOPAUSAL STATE 
    After menopause coronary disease accelerates in women. HDL levels fall 
post menopausally. Multiple observational and experimental trials have shown 
that oestrogen therapy in females lowers the coronary risk. In the Heart and 
Estrogen/Progesterone Replacement Study postmenopausal survivors of acute 
MI were randomized to estrogen/progesterone combination or a placebo. This 
study failed to show recurrence of CAD in patients in the therapeutic wing. The 
JUPITER trial randomized more than 6000 women over the age of 65 years 
without any CVS disease and with an LDL of <130 mg/dl but with hS-CRP 
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>2mg/L to statin versus placebo and found positive outcomes in the statin 
treated arm. 
DIABETES MELLITUS: 
   Glucose tolerance is divided into 3 categories- 
       1. Normal glucose homeostasis, 
       2. Diabetes mellitus and  
       3. Impaired homeostasis. A fasting glucose of <100 mg/dl, blood glucose 
level of <140 after a glucose challenge and a HbA1C of <5.6% are considered 
as normal glucose tolerance. 
CRITERIA TO DEFINE DIABETES MELLITUS 
Symptoms of diabetes (polyuria, polydipsia, polyphagia) plus 
1. Fasting blood glucose of >126 mg/dl or 
2. Blood glucose of >200 mg/dl after a 2 hour oral glucose challenge, or  
3. a HbA1c of >6.5% is considered as diabetes  
RISK FACTORS FOR DEVELOPING DIABETES 
    Family history of diabetes mellitus(parent or a sibling with Type 2 
diabetes) 
    Physical inactivity 
    Obesity 
    Race/ethnicity 
31 
 
    Previously diagnosed IGT or IFG or AIC>5.7 to 6.4% 
    History of gestational diabetes or a history of delivery of a baby 
weighing >4 kg 
    Hypertension 
    HDL <35 mg/dl or triglycerides >250 mg/dl 
    Polycystic ovarian disease 
    Metabolic syndrome 
    Acanthosis nigricans 
    History of cardiovascular disease 
The ADA recommends screening of all the persons more than 45 years of 
age every 3 years. Earlier screening is recommended if they are 
overweight (BMI>25 kg/sq.m) or there is an additional risk factor for 
diabetes. In contrast to long latency period before diagnosis in type 2 
diabetes there is no such lag period in case of type 2 sdiabetes. 
    Insulin resistance is central to the development of diabetes. 
Diabetes  (DM) has reached epidemic proportions worldwide, and its 
prevalence is on the rise. The implications of a diagnosis of diabetes are as 
severe as a diagnosing a coronary artery disease (CAD). Cardiovascular 
mortality increase in all age groups and for both sexes rises equivalently with 
Diabetes or a history of MI and the two are synergistic (Figure 1). In addition, 
DM (especially type 2 ), is associated with risk factors for cardiovascular 
disease (CVD). Amongst adults with DM there is  75% to 85% prevalence of 
hypertension, 70% to 80% for increased  LDL, and 60% to 70% association 
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with obesity.CAD is the main cause of death in both type 1 and type 2 diabetes  
and Diabetes is associated with a 2 to 4-fold increased mortality due to heart 
disease. Over 70% of people more than 65 years of age with Diabetes will die 
from s heart disease or stroke.Further, in patients with Diabetes, there is an 
increased mortality after Myocardial infarction, and worse long-term prognosis. 
 
 
Figure 1 
Event rates for endpoint of nonfatal MI, nonfatal stroke, and CV death in 
males(A) and females (B) stratified by age in relation to diabetes and a prior 
Myocardial infarction 
In the western world, one third of all percutaneous PCI procedures are done on 
patients with Diabetes and ~25% of patients undergoing CABG surgery have 
DM; the outcomes of these major procedures is less effective than in those 
patients without DM. DM modifies the body’s response to arterial injury, in the 
form of profound consequences in terms of risk for restenosis and stent 
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thrombosis. Although considerable improvement has been there in the 
management of patients with CAD,  the coronary event rates still remain high 
among patients with DM.Thus, optimal medical therapy and prompt selection 
of revascularization technique is critical for patients with DM.  
    The following literatures summarise  the current evidence regarding the 
effectiveness of multiple  and revascularization procedures in patients with 
diabetes. 
 
Glycemic control and CV outcomes 
DM, while it has been known since the antiquity, this disease can only be dated 
to the era after wide-spread insulin usage. Prior to insulin replacement, DM 
was a universally fatal disease primarily in children. The Diabetes mellitus of 
today, with its chronic manifestations, is due to the lifesaving and the life-
prolonging insulin effects and thus naturally many people have wondered how 
the―tight‖ control of blood sugar with precise insulin doses would affect CV 
risk. In general, tight glycemic control is associated with an higher risk for 
episodes of hypoglycemia but minimal or no mortality benefits. The ACCORD  
trial was designated to test if the treatment targeting  normal glycemic status 
reduces the risk of CV events in type 2 Diabetes. More than 10,000 patients 
enrolled were randomized into either a standard treatment protocol that aimed 
at a target HbA1c levels of 7% and 8% or an intensive strategy arm that aimed 
to attain an A1c value of less than 6.0%. The median HbA1c values with the 
standard strategy was found to be 7.5%; and the intensive strategy attained a 
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median A1c value of 6.4%.Still, the intensive strategy was associated with 
almost 22% increase in the all-cause mortality  and morbidity and the study 
was terminated after a median follow-up of around 3.4 years. 
The ADVANCE trial randomized 11,140 patients to a strategy of intensive 
glucose control (with primary therapy with the sulfonylurea drug gliclazide and 
also additional drugs as needed to attain a target A1c of <6.5%) versus a 
standard therapy, with the glycemic target  goal set as per  the ―local 
guidelines‖. The median A1c levels attained in the intensive versus standard 
arms were 6.3% and 7.0 percent, respectively.The Intensive treatment caused a 
relative decrease of 10% in the primary  outcome of major macrovascular 
disease events ; P=0.01, mainly due to reduction in nephropathy which is a 
microvascular sequelae 
The metabolic environment of diabetes mellitus may further impact 
negatively on the islet cell function for example in case of chronic 
hyperglycemia 
 
impairs islet function by a mechanism called as glucotoxixity and leads to 
further worsening of the glycemic status. Improvement in glycemic status 
causes improvement in islet function also. 
           Elevation of free fatty acid levels may also worsen islet cell 
function(lipotoxicity) 
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HYPERTENSIVE VASCULAR DISEASE 
    Hypertension doubles the risk of cardiovascular diseases. Blood pressure 
increases steadily in the first two decades of one’s lifetime. Blood pressure 
tracks over time in children and between adolescent and young adult. Among 
individuals more than 60 years women have higher BP than men. Among 
adults diastolic BP also increases till 55 years after which it tends to decrease. 
As a consequence the pulse pressure widens beyond 60 years of age. Thus the 
probability that an adult will develop hypertension during his lifetime is almost 
90%. Acculturation is an important contributor. 60% of the hypertensives are 
>20% overweight.  
    The age related increase in BP is augmented by high NaCl intake. Low 
intake of calcium and potassium may be also contribute. The urine sodium 
potassium ratio correlates strongly with BP than either alone. Alcohol intake, 
stress and low physical activity also contribute. Hypertension is a polygenic 
disease acting in concert with environmental factors. Genetic factors may also 
contribute to hypertensive nephropathy. 
Mechanisms of hypertension 
    Arterial pressure is determined by cardiac output and the total peripheral 
resistance. Cardiac output is the function of stroke volume and heart rate. 
Peripheral resistance is determined by the changes in the small arteries and 
arterioles (functional and anatomic changes). 
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    Hypertensives have stiffer arterioles. A number of devices like ultrasound 
and MRI are used to evaluate the arterial stiffness. Vascular endothelium also 
modulates vascular tone by producing vasodilators like nitric oxide which is a 
potent vasodilaltor. This endothelium dependent vasodilation is impaired in 
hypertensives. This is assessed by using high resolution ultrasound before and 
after the hyperemic phase of reperfusion after 5 minutes of forearm ischemia.  
    Endothelium dependent vasodilation is also assessed by i.v infusion of 
endothelium dependent vasodilators like acetyl choline. Endothelin is a 
vasoconstrictor peptide produced by the endothelium. Hypertensive heart 
disease is a consequence of the structural changes leading to LVH and CCF. 
Aggressive control of hypertension reverses the LVH. Several studies suggest 
that an ABI of<0.8 is associated with elevated BP especially systolic. 
    Home blood pressure and ambulatory blood pressure are generally lower 
than the office BP. BP is higher in the morning hours, thus MI and stroke are 
common in the early morning hours. Night time blood pressure is 10% to 20% 
less than daytime BP and an attenuated nocturnal dip is associated with 
increased CV risk. White coat hypertension is associated with increased CV 
risk.80-95% patients are diagnosed as essential hypertension. Essential 
hypertension tends to be familial. 
Measurement of blood pressure 
    Before the measurements are taken, individual should be seated quietly in a 
chair for 5 min, in a quiet room. At least 2 measurements should be made. The 
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centre of the cuff should be at the heart level and the width of the bladder cuff 
should be at least 40% of arm circumference. Cuff should be deflated at 
2mmHg/sec. SBP is the first koratkoff sound and the diastolic BP is the last 
koratkoff sound heard. Ambulatory measurements use the oscillometric method 
and typically take readings every 15 to 30 minutes. Blood pressure should be 
measured in both the upper limbs and in the supine, sitting and standing 
position. 
LAB INVESTIGATIONS IN A HYPERTENSIVE PATIENT: 
    Renal: 
        Urinalysis, albumin excretion, serum BUN / creatinine 
    Endocrine 
        Serum sodium, potassium, calcium, TSH  
    Metabolic 
        Fasting blood sugar, lipid profile 
    Others: 
         ECG  
        Hematocrit 
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DYSREGULATED COAGULATION OR FIBRINOLYSIS 
    The stability of the plaque depends on the balance between fibrinolytic 
system like plasmin and the antifibrinolytic system like plasminogen activator 
inhibitor. Patients with diabetes have elevated levels of PAI. Prophylactic 
Aspirin is beneficial in women with 10 year ASCVD risk of ≥20% and in men 
with 10 year ASCCD risk of ≥10% without CHD and for treatment of patients 
with established CHD. 
HOMOCYSTEINE: 
    Homocysteine has been implicated to be associated with CAD. But 
homocysteine levels should be measured only in young patients with CAD in 
those with atherosclerosis out of proportion to the risk factors. 
INFLAMMATION 
    Inflammation also contributes to coronary risk. Patients with elevated hs-
CRP levels have high cardiovascular risk. CRP serves as validated biomarker 
for risk but not as a direct contributor to the pathogenesis. CRP levels rise with 
body mass (obesity) and lower with weight reduction. Evidence suggests that 
lipid lowering therapy also acts by suppressing the inflammation 
LIFESTYLE MODIFICATION 
    Physicians should advise the patient on smoking cessation and about healthy 
dietary practices to maintain ideal body weight and to optimize the risk factors 
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long before the atherosclerotic disease manifests. Physical activity of at least 30 
minutes per day is needed. 
ISCHAEMIC HEART DISEASE 
CORONARY ATHEROSCLEROSIS 
    Epicardial coronaries are the major site of atherosclerosis. When the stenosis 
is >50% there is a limitation of the ability to increase the flow on demand. 
When the diameter is reduced by >80 % there is diminished flow even at rest. 
Critical occlusions of the Left main and the Left anterior descending artery are 
particularly hazardous. Chronic narrowing causes development of collaterals 
which may be sufficient to maintain myocardial viability but not during 
increased demand. 
     The normal myocardium converts fatty acids and glucose into CO2 and 
water. In severe oxygen deprivation fatty acids cannot be used up and the 
glucose is converted to lactic acid. The duration of the injury determines if the 
myocardial injury is reversible (<20 min in the absence of collaterals) or 
irreversible (>20 minutes). Ischemia also causes ECG changes like T wave 
inversion (non-transmural intra myocardial ischemia), transient ST depression 
reflecting patchy sub endocardial ischemia and ST elevation reflecting severe 
transmural ischemia. Exercise tests in asymptomatic patients may reveal 
evidence of silent myocardial ischemia. Coronary angiogram findings reveal 
plaques in these patients. In contrast to the asymptomatic phase of the disease 
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the symptomatic phase is characterized by chest discomfort either due to 
angina or due to Myocardial infarct. 
INVESTIGATIONS 
    Fasting lipid profile 
    Urine routine-to rule out microalbuminuria in diabetics 
    Blood sugar and HbA1c 
    Hematocrit and complete blood count 
    Creatinine 
    Thyroid function tests 
    Hs-CRP 
    Chest x-ray (to detect cardiomegaly, LV aneurysm) 
    Electrocardiogram 
        The 12 lead ECG in a patient with angina may be normal at rest or there 
may be features of old MI. Although repolarization abnormalities example ST-
T changes, left ventricular hypertrophy and intraventricular conduction changes 
may also be present they are non-specific. Dynamic ST-T changes that occur 
during anginal episodes and disappear thereafter are considered more specific. 
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 STRESS TESTING 
        It involves a standardized increment in work load while the symptoms, 
ECG and BP are monitored. Exercise duration is limited by symptoms and is 
stopped when there is severe chest discomfort or shortness of breath or 
dizziness or sever fatigue or when there is an ST depression of more than 2mm. 
         Fall in BP of more than 10mmHg or the development of ventricular 
arrhythmias. The ischemic ST segment response is defined as horizontal or 
down sloping depression of >1 mm and lasting longer than 0.08 seconds. T 
wave abnormalities, conduction disturbances and ventricular arrhythmias 
during the tests are non-diagnostic. Negative stress tests in which the target 
heart rate (85% of predicted heart rate during exercise) is not achieved is also 
non diagnostic. False positive and false negatives occur in one third cases. The 
overall sensitivity is only 75%.It cannot detect lesion of left circumflex since it 
is not represented on the surface ECG. 
         False positive tests seen in those with preexisting ST-T changes, digitalis 
and antiarrhythmic therapy, abnormal potassium levels and intra ventricular 
conduction abnormalities. Measure the total duration of exercise, the external 
work performed9the stage of exercise) and the internal cardiac work (product 
of heart rate and BP).Modified heart rate limited rather than symptom limited 
tests can be done in patients as early as 6 days after MI. Contraindications to 
stress testing include rest angina within 48 hours, unstable rhythm, severe 
aortic stenosis, acute myocarditis, CCF, pulmonary hypertension and infective 
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endocarditis. The development of angina or severe ST depression before stage 
II of Bruce protocol indicates severe IHD. 
CORONARY VASCULAR ANATOMY
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CORONARY ARTERIOGRAPHY: 
     It outlines the lumina of the coronary arteries and can be used to exclude 
significant coronary occlusion. But it does not provide information about the 
vessel wall and so severe form of atherosclerosis that does not encroach upon 
the lumina may not be diagnosed. Atherosclerosis initially causes bulging of 
the artery without encroaching on the lumen, a process called as remodeling. 
Later in the course of the disease it would cause luminal compromise. 
INDICATIONS FOR CAG 
     1. CAG is considered for chronic stable angina patients who are severely 
symptomatic despite medical management and are being considered for 
revascularization. 
     2.  Patient with troublesome symptoms to confirm the diagnosis of IHD. 
     3. Patients with known angina who have survived cardiac arrest. 
     4. Patients with ischemia on laboratory testing with clinical or lab evidence 
of LV dysfunction 
     5.  Patients a t high risk of sustaining coronary events based on signs of 
sever ischemia on non-invasive methods 
     6.  Negative or non-diagnostic stress test for confirming the diagnosis 
     7.  Patients with history of repeated admissions for suspected ACS but in 
whom the diagnosis is not confirmed 
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      8. Patients whose career involves the safety of other people (pilots, 
firefighters, police) in whom there is a suspicious or proven CAD by non-
invasive tests. 
      9. Patients with Aortic stenosis and hypertrophic cardiomyopathy in whom 
chest pain due to CAD cannot be excluded. 
      10.  Males >45 years and females > 55 years who undergo open cardiac 
procedures  like valve replacement or repair in whom here may be a preexisting 
asymptomatic CAD 
      11.  Patients after MI especially those at high risk for recurrence of angina 
or the presence of heart failure, frequent VPCs, or signs of ischemia on the 
stress tests 
      12. Patients with angina pectoris regardless of severity in whom non-
invasive tests indicate poor exercise performance or severe ischemia. 
       13. Patients in whom Coronary artery spasm or other non-atherosclerotic 
causes of MI are suspected, for example, Coronary artery anomaly, Kawasaki 
disease. 
Obstructive lesions of the left main coronary or the left anterior descending 
artery proximal to septal branch are associated with poor prognosis because of 
the greater area of myocardium at risk. Greater the number of risk factors, 
greater is the severity of coronary artery disease. 
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    Non-invasive alternatives to CAG are CT angiography and cardiac MR 
angiography. (limitations include higher radiation exposure with CT 
angiography compared with conventional angiography, motion artefacts 
associated with cardiac cycle during MR angiography). 
CORONARY ARTERY DISEASE AND PERIPHERAL ARTERIAL 
DISEASE ASSOCIATION 
    It is a well known fact that peripheral arterial disease is associated with other 
arterial diseases also especially coronary artery disease and cerebrovascular 
disease. 
    Peripheral arterial diseaseaffects approximately 16 percent of the population 
over the age of 55 years. 
    The association of CAD and PAD increases the risk of all cause mortality 
than while CAD and   PAD exist alone as single entities 
    Atherosclerosis is a systemic or a generalized disease process ,hence may 
affect any artery in the body from the head to foot. 
    But the most common clinical events rise from atheromatous process 
affecting the coronary arteries, the carotid arteries, the aorta, the arteries of the 
lower limbs. 
    Data from patients with suspected coronary disease who were subjected to 
coronary angiogram shows that the actual prevalence of Coronary artery 
disease ids high when evaluated by using ABI. 
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    Longevity itself is a risk factor associated with development of both 
Coronary as well as peripheral vascular disease. 
    ABI deterioration is associated with clear increase in mortality and morbidity 
in CAD patients 
    Excess risk is found in those with positive inflammatory biomarkers. The 
increased vulnerability to CAD is because of shared risk factors for the two 
diseases and by the presence of inflammation. 
    The predictive value of ABI in Cardiovascular mortality is comparable to 
that in Framingham Heart Study. 
    Combining ABI with traditional risk factors listed in Framingham Study of 
risk assessment would reclassify around 19 percent males and approximately 
36 percent females into the appropriate treatment categories. 
    An ABI of more than 1.4 is also a risk for all cause mortality and 
cardiovascular morbidity even if the observations were not diagnostic because 
of the vessel incompressibility. 
MODIFICATIONS OF THE ABI TECHNIQUE 
     Post exercise ABI measurements. Exercise unmasks patients with milder 
peripheral vascular disease.  
    But exercise ABI is not an option at all in patients with comorbidities due to 
respiratory or cardiac disease.  
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    Around 15% patients are not candidates for exercise ABI or for hyperemia 
induction (which mimics exercising with an occlusive cuff) 
  
  
 
 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
STUDY CENTRE:  
Madras Medical College and Rajiv Gandhi Government General 
Hospital  
STUDY DESIGN:  
Single centre observational study 
VENUE:  
Rajiv Gandhi Government General Hospital, Chennai 
COLLABORATING DEPARTMENTS: 
Institute of Internal Medicine and 
 Institute of Cardiology, Madras Medical College, Chennai 
SAMPLE SIZE  is calculated using the formula 4*p q/d where p denotes the 
prevalence of the disease, q=1-p and the error range is denoted by d. Using the 
above formula the sample size was  calculated to be 100. 
METHODOLOGY 
    A complete history was obtained from our patients who were admitted as 
inpatients in the medical and cardiology wards including the past history and 
the history of risk factors like diabetes, systemic hypertension, smoking and 
hyperlipidemia. 
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A complete physical examination including the vitals was done. 
Detailed cardiovascular examination was done and the findings were confirmed 
using an electrocardiogram. All the patients who were admitted with CAD (ST 
elevation MI and non ST elevation MI and unstable angina were subjected to 
coronary angiogram. The Ankle brachial index was measured in the study 
population and the results were compared. Treatment was given for the CAD 
and the risk factors as well. 
INCLUSION CRITERIA 
1.  Age >45 years 
2.  DIABETES: 
          Symptoms of diabetes plus random blood glucose levels ≥ 200 mg/dl or 
          Fasting glucose ≥126 mg/dl or 2 hour blood glucose ≥200 mg/dl or  
          The use of glucose lowering medication 
3. HYPERTENSION: 
         Systolic blood pressure of ≥140 mmHg or diastolic BP of ≥90 mmHg or 
         If the patient is taking antihypertensive treatment 
4. SMOKING: 
          Regular use of tobacco for smoking one or more times per day or 
          Patient has smoked in the past 30 days prior to hospital admission 
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5. DYSLIPIDEMIA: 
          Total cholesterol≥200 mg/dl or 
          LDL ≥130 mg/dl or 
          HDL levels ≤40 mg/dl in men and ≤ 50 mg/dl in women or 
          Triglycerides level≥200mg/dl or 
          History of treatment with lipid lowering drugs 
6. CORONARY ARTERY ANGIOGRAM 
EXCLUSION CRITERIA 
1. Patients with lower limb gangrene 
2. Patients with ABI >1.4 
3. Patients with deformity of upper or lower limbs 
4. Unclear results of ABI or coronary angiography 
5. Patients who did not give consent for the procedure 
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STATISTICAL ANALYSIS PLAN 
DATA ANALYSIS 
         Descriptive statistics was done for all data and were reported in terms of 
mean values and percentages.  
        Suitable statistical tests of comparison were done. Continuous variables 
were analysed with the unpaired t test. 
         Categorical variables were analysed with the Chi-Square Test and Fisher 
Exact Test. Statistical significance was taken as P < 0.05. 
         The data was analysed using SPSS version 16 and Microsoft Excel 2007. 
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SAMPLE SIZE ESTIMATION 
Sample size was determined based on  
Study  
Correlation between peripheral arterial disease and coronary artery disease 
using ankle brachial index—a study in Indian population 
Authored by 
Sharmistha Sarangi et al 
Published in 
Indian Heart Journal 6401 (2012) 2–6 
 
In this study, 45 patients (24.73%) in the study population had CAD. The 
occurrence of CAD in PAD-positive cases was 46.88% while in PAD-negative 
cases it was 20% (P = 0.001; statistically significant). (57% increased 
difference) 
 
Description: 
• The confidence level is estimated at 95% 
• with a z value of 1.96 
• the confidence interval or margin of error is estimated at +/-10 
• Assuming p% =57 and q%=43 
• Power of study at 80% 
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n = p% x q% x [z/e%] ² 
n= 57 x 43 x [1.96/10]² 
n= 95  
Therefore 95 is the minimum sample size required for the study. 
In my study I plan to recruit a minimum of 100 subjects  
STUDY PERIOD: 1 year( August 2017 to july 2018) 
CONSENT 
    All participants gave written/informed consent for the procedure 
ETHICAL COMMITTEE APPROVAL 
    Institutional Ethical Committee of Madras Medical College approved the 
study 
METHODS: 
    After measuring ABI patients were categorized into two groups that is ABI 
+ve group (an ABI of ≤0.9) and ABI-ve group those with an ABI of <0.9).All 
the patients who met the diagnostic criteria underwent diagnostic coronary 
angiography via the trans-femoral route with a 5F or 6F catheter. The dye used 
was Omnipaque300 (iohexol 647 mg, trometamol1.2 mg). Based on the 
findings the coronary lesions were classified as CAD group if the stenosis was 
>50% in the major epicardial coronary arteries.  
    These were further classified as  
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                    non-significant (<75% occlusion), 
                    significant (≥75-99% occlusion) and 
                    cut off (100% occlusion) respectively. The various vessel 
involvement (left main coronary artery, Left anterior descending, left 
circumflex,  right coronary, obtuse marginal 1 and 2)in different patients were 
recorded. 
  
  
 
 
 
OBSERVATION AND RESULTS 
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OBSERVATION 
    1. In this study, an analytical approach was adopted to determine the 
relationship between peripheral arterial disease and coronary artery disease in 
high risk population using ankle brachial index.  
 
    2. Data collected from 100 selected subjects were internally compared, 
tabulated, analysed and interpreted by using descriptive and inferential 
statistics based on the formulated objectives of the study 
  
Among the population studied 28 percent were ABI+VE and 72 percent were 
ABI –VE 
  
Study Groups ABI +ve Group ABI -ve Group Total 
Number 28 72 100 
Percentage 28.00 72.00 100.00 
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AGE DISTRIBUTION 
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Age Distribution ABI +ve Group ABI -ve Group Total 
Mean 56.00 55.61 55.72 
SD 6.78 5.96 6.17 
P value  
Unpaired t Test 
0.779 
 
 
  
 
 
 
Age Groups 
ABI +ve 
Group 
% 
ABI -ve 
Group 
% Total % 
41-50 years 7 25.00 17 23.61 24 24.00 
51-60 years 16 57.14 39 54.17 55 55.00 
61-70 years 5 17.86 16 22.22 21 21.00 
Total 28 100.00 72 100.00 100 100.00 
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It is evident from the age distribution table that most of the ABI+ve group 
subjects were in 51-60 years age group (57.14%) with a mean age of 56.00 
years. In ABI-ve group majority too were in 51-60 years age group (54.17%) 
with a mean age of 55.61 years. (p= G0.779). The data subjected to unpaired t 
test reveals the existence of statistically non-significant association between 
age distribution and ABI study groups (p > 0.05) 
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Gender 
Status 
ABI +ve 
Group 
% 
ABI -ve 
Group 
% Total % 
Male 17 60.71 54 75.00 71 71.00 
Female 11 39.29 18 25.00 29 29.00 
Total 28 100.00 72 100.00 100 100.00 
P value  
Chi Squared Test 
0.157 
 
It is evident from the gender status table that most of the ABI+ve group 
subjects were males (60.71%) and ABI-ve group subjects too were mostly 
males (75.00%) (p= 0.157). The data subjected to chi squared test reveals the 
existence of statistically non-significant association between gender status and 
ABI study groups (p > 0.05) 
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Diabetes 
Mellitus 
Status 
ABI +ve 
Group 
% 
ABI -ve 
Group 
% Total % 
Present 18 64.29 26 36.11 44 44.00 
Absent 10 35.71 46 63.89 56 56.00 
Total 28 100.00 72 100.00 100 100.00 
P value  
Chi Squared Test 
0.011 
 
It is evident from the diabetes mellitus status table that most of the ABI+ve 
group subjects were diabetics (64.29%) and ABI-ve group subjects were 
mostly non diabetics (63.89%) (p= 0.011). The data subjected to chi squared 
test reveals the existence of statistically significant association between 
diabetes mellitus status and ABI study groups (p < 0.05) 
Discussion 
In our study the diabetes mellitus status between the ABI+ve group and ABI-ve 
group was meaningfully significant. This is evident by the increased incidence 
of diabetes in ABI+ve group compared to ABI-ve group (mean increased 
difference of 28.17 percentage points, 44% higher).  
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HYPERTENSION STATUS 
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Hypertension 
Status 
ABI +ve 
Group 
% 
ABI -ve 
Group 
% Total % 
Present 20 71.43 30 41.67 50 50.00 
Absent 8 28.57 42 58.33 50 50.00 
Total 28 100.00 72 100.00 100 100.00 
P value  
Chi Squared Test 
0.008 
 
 
It is evident from the hypertension status table that most of the ABI+ve group 
subjects were hypertensive (71.43%) and ABI-ve group subjects were mostly 
non hypertensive (58.33%) (p= 0.008). The data subjected to chi squared test 
reveals the existence of statistically significant association between 
hypertension status and ABI study groups (p < 0.05) 
 
DISCUSSION 
In our study the hypertension status between the ABI+ve group and 
ABI-ve group was meaningfully significant. This is evident by the increased 
incidence of hypertension in ABI+ve group compared to ABI-ve group (mean 
increased difference of 29.76 percentage points, 42% higher).  
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Dyslipidemia 
Status 
ABI +ve 
Group 
% 
ABI -ve 
Group 
% Total % 
Present 16 57.14 23 31.94 39 39.00 
Absent 12 42.86 49 68.06 61 61.00 
Total 28 100.00 72 100.00 100 100.00 
P value  
Chi Squared Test 
0.020 
  
 
 
It is evident from the dyslipidemia status table that most of the ABI+ve group 
subjects had dyslipidaemia (57.14%) and ABI-ve group subjects mostly had no 
dyslipidemia (68.06%) (p= 0.020). The data subjected to chi squared test 
reveals the existence of statistically significant association between 
dyslipidemia status and ABI study groups (p < 0.05) 
 
 
DISCUSSION 
In our study the dyslipidemia status between the ABI+ve group and ABI-ve 
group was meaningfully significant. This is evident by the increased incidence 
of dyslipidemia in ABI+ve group compared to ABI-ve group (mean increased 
difference of 25.20 percentage points, 44% higher). 
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SMOKING STATUS 
 
 
 
 
16 
12 
31 
41 
0
5
10
15
20
25
30
35
40
45
Present Absent
N
u
m
b
e
r 
o
f 
P
at
ie
n
ts
 
Smoking Status 
ABI +ve Group ABI -ve Group
68 
 
 
 
Smoking 
Status 
ABI +ve 
Group 
% 
ABI -ve 
Group 
% Total % 
Present 16 57.14 31 43.06 47 47.00 
Absent 12 42.86 41 56.94 53 53.00 
Total 28 100.00 72 100.00 100 100.00 
P value  
Chi Squared Test 
0.205 
  
It is evident from the smoking status table that most of the ABI+ve group 
subjects were smokers (57.14%) and ABI-ve group subjects were mostly non 
smokers (56.94%) (p= 0.205). The data subjected to chi squared test reveals the 
existence of statistically non-significant association between smoking status 
and ABI study groups (p > 0.05) 
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CORONARY ARTERY DISEASE  STATUS 
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Coronary 
Artery 
Disease 
Status 
ABI +ve 
Group 
% 
ABI -ve 
Group 
% Total % 
Present 11 39.29 9 12.50 20 20.00 
Absent 25 89.29 55 76.39 80 80.00 
Total 36 128.57 64 88.89 100 100.00 
P value 
Chi Squared Test 
0.048 
 
 
It is evident from the CAD status table that most of the ABI+ve group subjects 
had no CAD (96.43%) and ABI-ve group subjects too mostly had no CAD 
(76.39%) (p= 0.048). The data subjected to chi squared test reveals the 
existence of statistically significant association between CAD status and ABI 
study groups (p < 0.05) 
 
DISCUSSION 
In our study the CAD status between the ABI+ve group and ABI-ve group was 
meaningfully significant. This is evident by the increased incidence of CAD in 
ABI+ve group (39.29%) compared to ABI-ve group (12.50%) (mean increased 
difference of 26.79 percentage points, 68% higher).  
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Vessel 
Involved 
ABI +ve 
Group 
% 
ABI -ve 
Group 
% Total % 
P value  
Chi 
Squared 
Test 
LMCA 6 21.43 10 13.89 16 16.00 0.356 
RCA 14 50.00 36 50.00 50 50.00 >0.999 
LAD 22 78.57 48 66.67 70 70.00 0.243 
D1 8 28.57 8 11.11 16 16.00 0.032 
D2 4 14.29 6 8.33 10 10.00 0.373 
OM 10 35.71 14 19.44 24 24.00 0.001 
LCX 14 50.00 26 36.11 40 40.00 0.203 
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It is evident from the vessel involved status table that most of the ABI+ve 
group subjects had LAD as vessel involved (78.57%) and ABI-ve group 
subjects too mostly had lad as vessel involved (66.67%) (p= 0.020). The data 
subjected to chi squared test reveals the existence of statistically significant 
association between vessel involved status (D1 and OM) and ABI study groups 
(p < 0.05) 
 
DISCUSSION 
In our study the vessel involved status between the ABI+ve group and ABI-ve 
group was meaningfully significant. This is evident by the 
 Increased incidence of D1 involvement in ABI+ve group compared to 
ABI-ve group (mean increased difference of 17.46 percentage points, 
61% higher).  
 Increased incidence of OM involvement in ABI+ve group compared to 
ABI-ve group (mean increased difference of 16.27 percentage points, 
46% higher) 
 
 
 
 
 
  
 
 
 
CONCLUSION 
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CONCLUSIONS 
We can conclude that: 
Among our study population, Age, gender and smoking status had no 
statistically significant role to play in determination of the relationship between 
peripheral arterial disease and coronary artery disease in high risk population 
using ankle brachial index  
This might be explained by the fact that older age is associated with stiff 
vessels and thus higher ABI values. 
On internal comparison the following conclusions were observed   
o ABI+ve patients associated with higher incidence of diabetes 
mellitus 
o ABI+ve patients associated with higher incidence of hypertension 
o ABI+ve patients associated with higher incidence of dyslipidemia 
o ABI+ve patients associated with higher incidence of CAD 
o The risk of coronary stenosis was significantly higher in ABI+ve 
patients with increased incidence of diagonal artery 1 (D1) and 
obtuse marginal artery (OM) involvements   
o An abnormal ABI was an independent predictor of CAD, lesions 
in coronary arteries and atherosclerotic risk factors 
This study is a hypothesis proving study.  
Hence results have high clinical significance. 
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LIMITATIONS OF THE STUDY 
    
1.  This study involves 100 patient samples only. Larger study groups are 
needed to establish the exact relationship between the various CAD risk factors 
and Ankle Brachial Index 
 2.   This study does not demonstrate the association between advancing age 
and ABI values 
  3.  Although Low ABI is associated with increased risk of CAD this study 
does not elicit any difference in the percentage of involved vessels among the 
ABI positive or negative groups 
  4.  There is also no statistically significant relationship between ABI and sex 
groups. This is probably due to similar risk of CAD and other atherosclerotic 
risk in postmenopausal women as compared to males. 
  5. There is also no statistically significant difference among smokers and non 
smokers probably due to lack of adequate control group  
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RECOMMENDATIONS 
 
1. Larger patient population sample and longer follow up period is required 
for more elaborate statistical analysis.  
2. These findings suggest clinical importance of ABI and its relationship to 
peripheral arterial disease and coronary artery disease in high risk 
population.  
3. Larger study population is probably needed to further investigate the 
effects of age, gender and smoking status on ABI and CAD risk 
4. This warrants further investigation of risk factors and early interventions 
to improve outcomes among these patients. 
5. To raise awareness among practitioners that ABI is a very simple way of 
assessing MACE events in the future and thus make use of ABI in 
routine clinical examination and screening. 
 
 
 
 
 
  
  
 
 
 
 
SUMMARY 
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SUMMARY 
This study shows that there is positive association between various risk 
factors like diabetes, hypertension, dyslipidemia and low ankle brachial index 
(which is an indicator of generalized atherosclerosis) and CAD thus supporting 
the fact that LOW ANKLE BRACHIAL INDEX IS A PREDICTOR OF 
CORONARY ARTERY DISAESE, hence necessitating screening of at risk 
individuals at an earlier stage using ABI. 
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PROFORMA 
Name 
Age 
Sex 
Occupation  
Address 
Contact number 
Symptoms 
1. Chest pain 
2. Dyspnea 
3. Intermittent claudication 
Patient characteristics 
1. Smoker (duration, number of cigarettes per day) 
2.  Alcoholic 
3. Diabetic (duration, if on treatment ) 
4. Hypertensive(duration and if on treatment) 
5. Coronary artery disease 
6. Peripheral vascular disease 
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Examination 
Systolic Blood pressure 
    Right upper limb 
    Right lower limb 
    Left upper limb 
    Left lower limb 
Pulse rate 
Ankle brachial index 
ECG 
Coronary angiogram findings 
PREVALENCE OF ATHEROSCLEROTIC RISK FACTORS IN ABI=VE 
AND ABI-VE PATIENTS 
Atherosclerotic 
risk factor 
ABI+VE ABI-VE Pvalue 
Diabetes    
Hypertension    
Dyslipidemia    
smoking    
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NON SIGNIFICANT AND SIGNIFICANT CUTOFF OCCLUSION OF 
DIFFERENT VESSELS ACCORDING TO ANGIOGRAPHIC FINDINGS IN 
ABI+VE AND ABI-VE PATIENTS 
 ABI+VE ABI-VE Pvalue 
LMA    
RCA    
LAD    
DI    
D2    
OM    
LCX    
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MEAN SD OF OCCLUSION OF DIFFERENT VESSELS ACCORDING TO 
THE ANGIOGRAPHIC FINDINGS IN ABI+VE AND ABI-VE PATIENTS 
 ABI+VE ABI-VE P VALUE 
LMCA    
RCA    
LAD    
DI    
D2    
OM    
LCX    
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INFORMATION SHEET 
    We are conducting a study on ―LOW ANKLE BRACHIAL INDEX AS A 
PREDICTOR OF CORONARY ARTERY DISEASE-A HOSPITAL BASED 
STUDY‖, among patients attending Rajiv Gandhi Government General 
Hospital,Chennai and for that your data will be valuable to us. 
    The purpose of the study is early diagnosis of CAD in patients with low ABI 
which is a marker of atherosclerosis that may aid in early treatment. 
    We are selecting certain cases and if you are found eligible,we me may use 
your clinical and lab parameters for our study. 
    The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the 
research, no personal information will be shared. 
    Taking part in the study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time. Your decision will not 
result in any loss of benefits to which you are otherwise entitled 
    The results of this special study may be intimated to you at the end of the 
study period Or during the study if anything is found abnormal which may aid 
in the management and treatment. 
Signature of the investigator                                     Signature of the participant 
Date 
Place 
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PATIENT CONSENT FORM 
Study Detail : “LOW ANKLE BRACHIAL INDEX AS A PREDICTOR OF 
CORONARY ARTERY DISEASE-A HOSPITAL BASED 
STUDY” 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
Identification Number :  
                                               Patient may check (√) these boxes 
a) I confirm that I have understood the purpose of procedure for the above study. I have 
the opportunity to ask question and all my questions and doubts have been answered 
to my complete satisfaction. 
❏ 
b) I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving reason, without my legal rights being affected. 
❏ 
c) I understand that sponsor of the clinical study, others working on the sponsor’s 
behalf, the ethical committee and the regulatory authorities will not need my 
permission to look at my health records, both in respect of current study and any 
further research that may be conducted in relation to it, even if I withdraw from the 
study I agree to this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published, unless as required 
under the law. I agree not to restrict the use of any data or results that arise from this 
study. ❏ 
d) I agree to take part in the above study and to comply with the instructions given 
during the study and faithfully cooperate with the study team and to immediately 
inform the study staff if I suffer from any deterioration in my health or well being or 
any unexpected or unusual symptoms. 
❏ 
e) I hereby consent to participate in this study. ❏ 
f) I hereby give permission to undergo detailed clinical examination and blood 
investigations as required. 
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